Hematology/Oncology Flashcards

1
Q

MCV?

A

Mean corpuscular volume:

- The average volume or size of a single RBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MCH?

A

Mean Corpuscular Hemoglobin:

- Average amount of hemoglobin in RBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MCHC?

A

Mean corpuscular hemoglobin concentration

- similar to MCH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RBW

A

Red Blood Cell distribution width

  • Indication of the variation of RBC size.
  • Indicator for anisocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Peripheral Blood smear?

A

Involves spreading a drop of blood thinly onto a glass slide.
- Gives info on number, shape and general appearance of blood cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of anemia?

A

Increased demand: rapid growth, prego, epo tx
Increased Fe loss: blood loss, menses, etc.
Decreased Fe absorption: diet, malabsorption (celiacs, crohn’s), surgery, inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

S/sx: of anemia?

A

Fatigue, tachycardia, palpations, dyspnea on exertion.

Severe: skin/mucosal changes (smooth tongue, brittle nails, koilonychia = spooning of nails, cheilosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Iron deficiency anemia?

A

microcytic
Eti: most often due to blood loss, also decreased absorption
Dx: Hb and HCT low, serum ferritin levels less than 12, serum Fe low, TIBC (total iron binding capacity) high, reticulocyte count, MCV and MCHC low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

B12 deficiency etiology

A

macrocytic
Pathophys: folate and B12 are required for DNA synthesis and effect normal cell growth and leads toward macrocyctosis
Eti: lack of intrinsic factor (IF enables body to absorb B12); altered pH in small intestine; diet, pernicious anemia (autoimmune against parietal cells or IF), bariatric surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

B12 deficiency s/sx

A

Can lead to changes in the muscosal cells:
- glossitis, GI issues (anorexia, diarrhea)
Neuro: paresthesias that can lead to difficulties with balance and proprioception
Cognition: AMS, memory changes, other neuropsych sx.
Can cause jaundice, leukopenia, thrombocytopenia
Hypersegmentation of neutrophils on peripheral blood smear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

B12 deficiency Dx and Tx:

A
  • Low serum B12 and elevated MCV
  • Hypersegmented neutrophils
  • Reduced reticulocyte
  • elevated lactate dehydrogenase
  • modest increase in bilirubin
  • increase in MMA and homocysteine
  • differentiate from folic acid def
    Tx: B12 IM or SubQ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Folate deficiency etiology

A
  • Most common cause inadequate dietary
  • ETOH, anorexic patients
  • diet low in fruits and veggies
  • Drugs: phenytoin (tx: seizures) , TMP-SMX, sulfasalazine (treats ulcerative colitis and RA)
  • Folic acid requirements go up in pregnancy, hemolytic anemia, exfoliative skin disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Folate deficiency S/sx:

A

Similar to B12 def, except no neurologic abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is PT in hemotology?

A

Prothrombin time
Used to evaluate the extrinsic pathway and the common pathway of the coagulation cascade.
It can be reported in INR, international normalized ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is aPTT?

A

Activated partial thromboplastin time.
Used to evaluate the intrinsic coagulation system and the common pathway.
Most often used to monitor heparin therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Reference range for platelets

A

normal: 150,000 to 400,000.

spontaneous bleeding risk starts at less than 20,000

17
Q

What are FSP

A

Fibrin split products:

Used to document a fibrin clot, shows thrombosis occurring in a patient

18
Q

Direct coombs test?

A

Used to identify immune hemolysis or to investigate a transfusion reaction.
- Demonstrates if RBCs have been attack by antibodies in patients own blood

19
Q

Indirect Coombs test?

A

Used to identify circulating AntiBs against RBCs.

Can detect minor serum antibodies other than major ABO/Rh system

20
Q

INR?

A

standard way of reporting PT time.

21
Q

D-dimer?

A

Used to assess thrombin an plasmin activity.
D-dimer is a fibrin degradation fragment that is made through lysis of cross-linked fibrin.
Think: DIC, PE, DVT, sickle cell, malignancy

22
Q

Thrombocytopenia etiology?

DDx?

A

Eti: Decreased bone marrow production, sequestration, enlarged liver, increased platelet destruction.
DDX: Infection-induced thrombocytopenia, drug-induced T, Heparin-induced T, immune T, inherited T, thrombotic thrombocytopenic purpura

23
Q

S/sx of thrombocytopenia?

Dx?

A

Petechia, possible spleenomegaly, bruising

Dx: CBC, bone marrow eval, anti-heparin/PF4, HIV, Hep C

24
Q

Thrombocytosis. Eti?

A

Body produces too many platelets
Eti: Iron deficiency, inflammation, cancer, infection.
Can also be: essential thrombocythemia, or polycythemia vera

25
Q

Thrombocytosis S/sx?

Risk?

A

S/sx: HA, visual sxs, lightheadness, atypical chest pain, acral dysesthesia
Risk: increased thombotic risk

26
Q

Aspirin. MOA, indic, CI, AE, interactions

A

MOA: irreversibly inhibits Cox 1 and 2 and blocks formation of thromboxane A2
CI; asthma, rhinitis, nasal polyps
AE: bleeding, duodenal ulcer, angioedema, bronchospasm, hepatotoxicity
Interaction: may diminish effect of ACE, w/ETOH increased liver tox.
Max dose: 4 g in 24hrs

27
Q

Heparin

A

MOA: inactivates thrombin and IX,X,XI,XII
Indic: prophylaxis of DVT. STEMI, NSTEMI
CI: recent bleed, thrombocytopenia
AE: heparin induced thrombocytopenia, bleeding risk

28
Q

LMWH

A
Low molecular weight heparin
MOA: Inactivates Xa.
Indic: Thromboprophylaxis
CI: active major bleed, thrombocytopenia
Inter: concomitant use of anticoags or platelet inhibitors
29
Q

Warfarin

A

MOA: inhibits K dependent factors: II, VII, IX,X, protein C and S
Indic: proph of thromboembolic disorders, a-fib or valve replacement
CI: Prego, bleeding, GI ulceration, recent eye/CNS surgery
Interaction: ETOH, othe coag/platelet agents
Pt. ed: Monitor leafy green intake and monitor INR

30
Q

Ticlodipine (Ticlid)

A

MOA: irreversibly blocks GPIIb/IIa, reduces platelet aggregation
Indic: used for those intolerant of aspirin

31
Q

Clopidogrel (Plavix)

A

MOA: irreversibly blocks GPIIb/IIa, reduces platelet aggregation
Indic: Unstable angina, NSTEMI, STEMI, recent MI, TIA, CVA, PAD